Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Mucosan Childrens Multi-Symptom Grape

Last content change checked dailysee data sync status

Active ingredients
  • Guaifenesin 50 mg/5 mL
  • Dextromethorphan Hydrobromide 5 mg/5 mL
  • Phenylephrine Hydrochloride 2.5 mg/5 mL
Other brand names
Drug classes
Expectorant, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, alpha-1 Adrenergic Agonist
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
January 8, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredients
  • Guaifenesin 50 mg/5 mL
  • Dextromethorphan Hydrobromide 5 mg/5 mL
  • Phenylephrine Hydrochloride 2.5 mg/5 mL
Other brand names
Drug classes
Expectorant, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, alpha-1 Adrenergic Agonist
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
January 8, 2026
Manufacturer
Menper Distributors, Inc.
Registration number
M012
NDC root
53145-691
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

MUCOSAN CHILDREN is a medication designed to help loosen phlegm (mucus) and thin bronchial secretions, making it easier for you to drain your bronchial tubes. It is commonly used to relieve symptoms associated with a cold, such as nasal congestion and cough caused by minor irritation in the throat and bronchial area.

By temporarily alleviating these symptoms, MUCOSAN CHILDREN can help you feel more comfortable when dealing with the discomfort of a cold.

Uses

This medication is designed to help you breathe easier by loosening phlegm (mucus) and thinning bronchial secretions, which allows for better drainage of your bronchial tubes. If you're experiencing symptoms from a cold, such as nasal congestion or a cough caused by minor irritation in your throat and bronchial area, this medication can provide temporary relief.

It's important to note that there are no reported teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects associated with this medication. Always consult with your healthcare provider if you have any questions or concerns about its use.

Dosage and Administration

When using this medication, it's important to follow the dosing guidelines carefully to ensure safety and effectiveness. You should never take more than 6 doses within a 24-hour period. To measure your dose accurately, always use the dosing cup that comes with the product, and keep it handy for future use. Remember, 1 teaspoon (TSP) is equal to 5 mL.

For children aged 6 to under 12 years, the recommended dose is 2 teaspoons (10 mL) every 4 hours. If your child is between 4 and under 6 years old, they should take 1 teaspoon (5 mL) every 4 hours. However, if your child is under 4 years old, this medication should not be used. Always adhere to these guidelines to ensure the best care for your child.

What to Avoid

If you experience nervousness, dizziness, or sleeplessness while using this medication, it's important to stop taking it and consult your doctor. Additionally, if your symptoms do not improve within 7 days or if they are accompanied by a fever, you should also seek medical advice. Be sure to stop use and contact your healthcare provider if your cough lasts more than 7 days, returns, or is accompanied by a fever, rash, or a persistent headache. Your health and safety are paramount, so don’t hesitate to reach out for help if needed.

Side Effects

If you experience nervousness, dizziness, or sleeplessness while using this medication, it's important to stop use and consult your doctor. Additionally, if your symptoms do not improve within 7 days, or if they are accompanied by a fever, you should seek medical advice. A cough that lasts more than 7 days, returns, or is accompanied by fever, rash, or a persistent headache may also indicate a more serious condition, and you should contact your healthcare provider.

Warnings and Precautions

It's important to be cautious when using this medication, especially for children. Do not give it to a child who is currently taking a monoamine oxidase inhibitor (MAOI) for depression, psychiatric conditions, or Parkinson's disease, or for two weeks after stopping an MAOI. If you're unsure whether your child's medication contains an MAOI, please consult a doctor or pharmacist.

Before using this product, check with a doctor if your child has any of the following conditions: heart disease, diabetes, high blood pressure, thyroid disease, a chronic cough (like asthma), or a cough with excessive mucus. If your child experiences nervousness, dizziness, or sleeplessness, or if symptoms do not improve within seven days or are accompanied by fever, stop using the medication and contact a doctor. Additionally, if a cough lasts more than seven days, returns, or is accompanied by fever, rash, or a persistent headache, seek medical advice as these may indicate a more serious issue. In case of an overdose, get emergency help or contact a Poison Control Center immediately at 1-800-222-1222.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's always important to be aware of the signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, you should contact your local emergency services or go to the nearest hospital right away. Having the medication packaging or information on hand can help medical professionals provide the best care. Always remember that when it comes to medications, it's better to be safe and get help if you have any concerns.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that the safety of Mucosan Children's Multi-Symptom Grape during pregnancy has not been established. Therefore, you should consult your doctor before using this product. While specific risks to the fetus are not detailed, caution is advised, and discussing your options with a healthcare provider is strongly recommended.

There are no specific dosage adjustments provided for pregnant individuals, but it's always best to err on the side of caution. Make sure to have an open conversation with your healthcare provider about any medications or supplements you are considering during your pregnancy.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to know that there is no specific information available about the effects of this medication on nursing mothers or lactation (the process of producing breast milk). Since the insert does not provide guidance on these topics, it’s advisable to consult your healthcare provider for personalized advice and to discuss any potential risks or concerns related to your situation. Your healthcare provider can help ensure that both you and your baby remain healthy while breastfeeding.

Pediatric Use

It's important to be cautious when giving medication to children. You should not use this medication if your child is currently taking a prescription monoamine oxidase inhibitor (MAOI) or has stopped taking one within the last two weeks. Before using it, consult your doctor if your child has any of the following conditions: heart disease, diabetes, high blood pressure, thyroid disease, a chronic cough (like asthma), or a cough with excessive mucus.

For dosing, children aged 6 to under 12 years can take 2 teaspoons (10 mL) every 4 hours, while those aged 4 to under 6 years should take 1 teaspoon (5 mL) every 4 hours. This medication is not recommended for children under 4 years old. Always keep the medication out of reach of children, and in case of an overdose, seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, it’s always a good idea to discuss any medications with a healthcare provider. They can help ensure that the treatment is safe and appropriate, considering any unique health needs or conditions that may be present.

Since there are no dosage adjustments or special precautions mentioned for elderly patients, your healthcare provider will be the best resource for personalized advice. Always keep them informed about any other medications or health issues to ensure safe and effective care.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition. This means that the information available does not provide special monitoring or safety considerations tailored for patients with renal impairment (kidney issues).

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help determine the best course of action based on your individual situation.

Drug Interactions

It's crucial to talk to your healthcare provider before using this medication, especially if your child is currently taking a monoamine oxidase inhibitor (MAOI) or has stopped taking one within the last two weeks. MAOIs are a type of prescription medication that can interact seriously with this drug, so caution is necessary.

Additionally, if your child is using any other oral nasal decongestants or stimulants, make sure to consult with a doctor or pharmacist. This will help prevent any potential drug interactions that could affect your child's health. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 15-30°C (59-86°F). It's important not to refrigerate it, as this can affect its effectiveness.

When handling the product, make sure to do so in a clean environment to maintain its integrity. Always follow any specific instructions provided for safe use and disposal to ensure your safety and the product's effectiveness.

Additional Information

No further information is available.

FAQ

What is MUCOSAN CHILDREN used for?

MUCOSAN CHILDREN helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes, temporarily relieving nasal congestion and cough due to minor throat and bronchial irritation.

What is the recommended dosage for children?

For children 6 to under 12 years, the dosage is 2 teaspoons (10 mL) every 4 hours. For children 4 to under 6 years, it is 1 teaspoon (5 mL) every 4 hours. Do not use in children under 4 years.

Are there any contraindications for using MUCOSAN CHILDREN?

Do not use MUCOSAN CHILDREN in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping the MAOI drug.

What should I do if my child experiences side effects?

Stop use and ask a doctor if your child experiences nervousness, dizziness, or sleeplessness, or if symptoms do not improve within 7 days or are accompanied by fever.

Is MUCOSAN CHILDREN safe to use during pregnancy?

The safety of MUCOSAN CHILDREN during pregnancy has not been established, so it is recommended to consult a healthcare provider before use.

What should I do in case of an overdose?

In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222.

How should MUCOSAN CHILDREN be stored?

Store MUCOSAN CHILDREN at 15-30°C (59-86°F) and do not refrigerate.

Packaging Info

Below are the non-prescription pack sizes of Mucosan Childrens Multi-Symptom Grape (dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mucosan Childrens Multi-Symptom Grape.
Details

Drug Information (PDF)

This file contains official product information for Mucosan Childrens Multi-Symptom Grape, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the relief of symptoms associated with colds, specifically nasal congestion and cough due to minor throat and bronchial irritation. It aids in loosening phlegm (mucus) and thinning bronchial secretions, facilitating drainage of the bronchial tubes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should advise patients to adhere strictly to the following dosage and administration guidelines.

The maximum dosage should not exceed 6 doses within a 24-hour period. It is essential to measure the medication using the dosing cup provided with the product to ensure accurate dosing. The dosing cup should be kept with the product at all times to facilitate proper measurement.

For children aged 6 to under 12 years, the recommended dosage is 2 teaspoons (10 mL) every 4 hours. For children aged 4 to under 6 years, the dosage is 1 teaspoon (5 mL) every 4 hours. It is important to note that the product is not recommended for use in children under 4 years of age.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to discontinue use and consult a healthcare professional under the following circumstances:

  • If nervousness, dizziness, or sleeplessness occurs.

  • If symptoms do not improve within 7 days or are accompanied by fever.

  • If a cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache.

Warnings and Precautions

It is imperative to adhere to the following warnings and precautions when considering the use of this medication in pediatric patients.

Warnings The use of this medication is contraindicated in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past two weeks. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, and Parkinson's disease. If there is uncertainty regarding whether a child's prescription includes an MAOI, it is essential to consult a healthcare professional, such as a doctor or pharmacist, prior to administration.

General Precautions Before administering this medication, it is advisable to consult a healthcare provider if the child has any of the following conditions:

  • Heart disease

  • Diabetes

  • High blood pressure

  • Thyroid disease

  • A chronic cough, particularly one associated with asthma

  • A cough that produces excessive phlegm (mucus)

Emergency Medical Help Instructions In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222 without delay.

Stop Taking and Call Your Doctor Instructions The medication should be discontinued and a healthcare provider consulted if any of the following occur:

  • Nervousness, dizziness, or sleeplessness

  • Symptoms do not improve within 7 days or are accompanied by fever

  • A cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

Side Effects

Patients should be advised to discontinue use and consult a healthcare professional if they experience nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days or are accompanied by fever, medical advice should be sought. A cough that persists for more than 7 days, recurs, or is associated with fever, rash, or a persistent headache may indicate a serious underlying condition and warrants immediate medical attention.

Drug Interactions

The use of this medication is contraindicated in pediatric patients who are concurrently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing an MAOI. This is due to the potential for serious interactions that may arise from such combinations.

Additionally, it is advised that caregivers consult a healthcare professional, such as a doctor or pharmacist, prior to administering this medication if the child is currently using any other oral nasal decongestants or stimulants. This precaution is necessary to mitigate the risk of possible drug interactions that could adversely affect the child's health.

Packaging & NDC

Below are the non-prescription pack sizes of Mucosan Childrens Multi-Symptom Grape (dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mucosan Childrens Multi-Symptom Grape.
Details

Pediatric Use

Pediatric patients should not use this medication if they are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of stopping an MAOI. Prior to administration, it is advisable to consult a healthcare professional if the child has any of the following conditions: heart disease, diabetes, high blood pressure, thyroid disease, a chronic cough (such as that associated with asthma), or a cough accompanied by excessive phlegm.

Dosing recommendations for pediatric patients are as follows: for children aged 6 to under 12 years, the recommended dose is 2 teaspoons (10 mL) every 4 hours; for children aged 4 to under 6 years, the recommended dose is 1 teaspoon (5 mL) every 4 hours. This medication is not recommended for children under 4 years of age.

It is important to keep this medication out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of Mucosan Children's Multi-Symptom Grape during pregnancy has not been established. Pregnant patients or those planning to become pregnant are advised to consult a healthcare provider prior to use. While specific risks to the fetus are not detailed, caution is recommended when considering this product during pregnancy. There are no specific dosage modifications for pregnant individuals provided in the labeling. It is essential for women of childbearing potential to discuss the use of this product with their healthcare provider to ensure informed decision-making regarding potential risks and benefits.

Lactation

There is no specific information available regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or relevant toxicology resources for guidance on management strategies tailored to the specific circumstances of the overdosage event.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222.

Patients should be informed to discontinue use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days or are accompanied by fever, or if a cough persists for more than 7 days, returns, or is associated with fever, rash, or a persistent headache, they should seek medical attention, as these may indicate a serious condition.

It is important for healthcare providers to recommend that patients consult a doctor before using the medication if the child has any of the following conditions: heart disease, diabetes, high blood pressure, thyroid disease, a chronic cough such as that associated with asthma, or a cough that produces excessive phlegm (mucus).

Furthermore, patients should be advised to speak with a doctor or pharmacist before using the medication if the child is currently taking any other oral nasal decongestant or stimulant to avoid potential interactions.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30°C (59-86°F). Refrigeration is not recommended, as it may compromise the integrity of the product. Proper storage conditions must be maintained to ensure optimal efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Mucosan Childrens Multi-Symptom Grape, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Mucosan Childrens Multi-Symptom Grape, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.